Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer

Kaya D. M., Orturk B., Kubilay P., Onur H., UTKAN G., ÇAY ŞENLER F., ...Daha Fazla

FUTURE ONCOLOGY, cilt.14, sa.15, ss.1461-1467, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 15
  • Basım Tarihi: 2018
  • Doi Numarası: 10.2217/fon-2017-0608
  • Dergi Adı: FUTURE ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1461-1467
  • Anahtar Kelimeler: prognosis, resectable breast cancer, vitamin D, 25-HYDROXYVITAMIN D LEVELS, 1,25-DIHYDROXYVITAMIN-D3, CHEMOTHERAPY, TRIAL, CELLS
  • Ankara Üniversitesi Adresli: Evet

Özet

Aim: There are inconsistent results about the effects of vitamin D level on breast cancer prognosis. We aimed to investigate the effect of vitamin D levels on the prognosis of resectable breast cancer in a patient group with highly different clothing styles. Patients & methods: A total of 186 breast cancer patients were enrolled in the study. Results: Vitamin D level was sufficient, insufficient and deficient in 17.2, 52.2 and 30.6% of patients, respectively. There was a significant relationship between clothing style and serum 25 (OH) D levels. We could not establish any relation between vitamin D level and tumor characteristics or survival. Conclusion: Vitamin D supplementation can be more important than diagnostic serum vitamin D level on prognosis of breast cancer.